These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10717526)

  • 1. Expression of telomerase component genes in hepatocellular carcinomas.
    Takahashi S; Kitamoto M; Takaishi H; Aikata H; Kawakami Y; Nakanishi T; Shimamoto F; Tahara E; Tahara H; Ide T; Kajiyama G
    Eur J Cancer; 2000 Mar; 36(4):496-502. PubMed ID: 10717526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma.
    Toshikuni N; Nouso K; Higashi T; Nakatsukasa H; Onishi T; Kaneyoshi T; Kobayashi Y; Kariyama K; Yamamoto K; Tsuji T
    Br J Cancer; 2000 Feb; 82(4):833-7. PubMed ID: 10732755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
    Takuma Y; Nouso K; Kobayashi Y; Nakamura S; Tanaka H; Matsumoto E; Fujikawa T; Suzuki M; Hanafusa T; Shiratori Y
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
    Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
    J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
    Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma.
    Nagao K; Tomimatsu M; Endo H; Hisatomi H; Hikiji K
    J Gastroenterol; 1999 Feb; 34(1):83-7. PubMed ID: 10204615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
    Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
    Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of PinX1 in human hepatocellular carcinoma.
    Oh BK; Chae KJ; Park C; Park YN
    Oncol Rep; 2004 Oct; 12(4):861-6. PubMed ID: 15375513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
    Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C
    Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma.
    Onishi T; Nouso K; Higashi T; Toshikuni N; Nakatsukasa H; Kobayashi Y; Uemura M; Yumoto E; Fujiwara K; Sato S; Nakamura S; Yokoyama J; Hanafusa T; Shiratori Y
    J Gastroenterol Hepatol; 2003 Oct; 18(10):1168-74. PubMed ID: 12974904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomeric 3' overhangs in chronic HBV-related hepatitis and hepatocellular carcinoma.
    Lee JE; Oh BK; Choi J; Park YN
    Int J Cancer; 2008 Jul; 123(2):264-272. PubMed ID: 18449889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal expression of hepatomas and circulating telomerase and its clinical values.
    Wu W; Yao DF; Qiu LW; Wu XH; Yao M; Su XQ; Zou L
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):544-9. PubMed ID: 16286259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCR and in situ hybridization studies of telomerase subunits in human non-neoplastic livers.
    Harada K; Yasoshima M; Ozaki S; Sanzen T; Nakanuma Y
    J Pathol; 2001 Feb; 193(2):210-7. PubMed ID: 11180168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.
    Miura N; Shiota G; Nakagawa T; Maeda Y; Sano A; Marumoto A; Kishimoto Y; Murawaki Y; Hasegawa J
    Oncology; 2003; 64(4):430-4. PubMed ID: 12759542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
    El-Mazny A; Sayed M; Sharaf S
    Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.
    Stefanou N; Papanikolaou V; Furukawa Y; Nakamura Y; Tsezou A
    BMC Cancer; 2010 Aug; 10():442. PubMed ID: 20723213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of telomerase reverse transcriptase and its relationship with tumor suppressor gene p53 in HCC].
    Dai D; Zhai W; Zhu T; Zhu H; Ling Y
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():79-81. PubMed ID: 11509149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma.
    Chen CJ; Kyo S; Liu YC; Cheng YL; Hsieh CB; Chan DC; Yu JC; Harn HJ
    World J Gastroenterol; 2004 Mar; 10(5):638-42. PubMed ID: 14991929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
    Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
    Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.
    Oh BK; Kim H; Park YN; Yoo JE; Choi J; Kim KS; Lee JJ; Park C
    Lab Invest; 2008 Feb; 88(2):144-52. PubMed ID: 18158557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.